Research on Molecular Mechanism of Fructus Ligustri Lucidi against Osteoporosis based on Network Pharmacology
DOI:
https://doi.org/10.1590/s2175-97902022e19856%20Keywords:
Fructus Ligustri Lucidi, Traditional Chinese medicine, Network pharmacology, Osteoporosis, TargetAbstract
This study aimed to investigate the molecular mechanism of Fructus Ligustri Lucidi (NZZ, Chinese abbreviation) against osteoporosis (OP) by means of network pharmacology.ChemDraw Professional 15.1 software and Molinspiration Smiles database were used to draw the chemical formulas of the components. The active ingredients and related target proteins of NZZ were searched in platform of systematic pharmacology of traditional Chinese medicine database, Drugbank, Therapeutic Target Database, SymMap and other databases. Gene Ontology(GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were carried out on the selected target through Enrichr and KEGG Automatic Annotation databases, and their mechanism was studied. A total of 29 compounds and 140 corresponding targets, including 14 key targets and 14 protein factors in protein-protein interaction core network were obtained. The key targets were tumor necrosis factor(TNF), interleukin(IL)-6R and sestrogen receptor alpha. The number of GO items was 466 (P<0.05), including 399 items of biological process (BP), 54 items of cell composition (MF) and 13 items of molecular function (CC). KEGG pathway enrichment screened 85 signaling pathways (P<0.05), including the IL-17 signaling pathway, TNF signaling pathway, advanced glycation end products and their receptors signaling pathway and cAMP signaling pathway. The active ingredients of NZZ. exert their anti-OP effects through multi-components, multi-targets and multi-pathways, which can provide new evidence for further study of their anti-OP mechanism.
Downloads
References
Bukhari S, Hussain F, Thu HE, Hussain Z. Synergistic effects of combined therapy of curcumin and Fructus Ligustri Lucidi for treatment of osteoporosis: cellular and molecular evidence of enhanced bone formation. J Integr Med. 2019;17(1):38-45.
Chen B, Wang L, Li L, Zhu R, Liu H, Liu C, et al. Fructus Ligustri Lucidi in Osteoporosis: A Review of its Pharmacology, phytochemistry, pharmacokinetics and safety. Molecules. 2017;22(9):1469.
Chen HS, Hutter CM, Mechanic LE, Amos CI, Bafna V, Hauser ER, et al. Genetic simulation tools for post-genome wide association studies of complex diseases. Genet Epidemiol. 2015;39(1):11-19.
Gan D, Xu X, Chen D, Feng P, Xu Z. Network Pharmacology-Based Pharmacological Mechanism of the Chinese Medicine Rhizoma drynariae Against Osteoporosis. Med Sci Monit. 2019;(25):5700-5716.
Kastner M, Sawka AM, Hamid J, Chen M, Thorpe K, Chignell M, et al. A knowledge translation tool improved osteoporosis disease management in primary care: an interrupted time series analysis. Implement SCI. 2014;(9):109.
Lei MM. LZGW Pathogenesis of secondary osteoporosis. Chin J Osteopor. 2018;24(11):1514-1520.
Liu R, Kang X, Xu L, Nian H, Yang X, Shi H, et al. Effect of the combined extracts of herba epimedii and fructus ligustri lucidi on sex hormone functional levels in osteoporosis rats. Evid-based Complementary Altern. 2015;2015:1-13.
Liu RH, Kang X, Xu LP, Nian HL, Yang XW, Shi HT, et al. Effects of the combined extracts of Herba Epimedii and Fructus Ligustri Lucidi on bone mineral content and bone turnover in osteoporotic rats. BMC Complement Altern Med. 2015;15(1):1-18.
Ngo QT, Lee HS, Nguyen VT, Kim JA, Woo MH, Min BS. Chemical constituents from the fruits of Ligustrum japonicum and their inhibitory effects on T cell activation. Phytochemistry. 2017;(141):147-155.
Ouni E, Vertommen D, Amorim CA. The human ovary and future of fertility assessment in the Post-Genome Era. Int J Mol Sci. 2019;17(20).
Song L, Xie XB, Peng LK, Yu SJ, Peng YT. Mechanism and Treatment Strategy of Osteoporosis after Transplantation. INT J Endocrinol. 2015;(2015):280164.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
